The ever increasing need to accelerate time to market for new drugs places a burden on analytical labs in terms of sample volume and confidence in data required for decision making. Innovations in trapped ion mobility mass spectrometry and software give BioPharma scientists new tools to characterize biologic drugs with more speed and keep up with the pace of development. Mass spectrometry imaging is becoming an essential tool to understand diseases and determine drugs PK and metabolism which are essential to address the right tissue and evaluate toxicity early.
For Research Use Only. Not for use in clinical diagnostic procedures.